<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1810482/open_sms">We love to hear from our listeners. Send us a message.</a><a href='http://www.cellandgene.com/'>Cell &amp; Gene</a>, the online resource that delivers in-depth content from authoritative authors and sources to professionals in the CGT sector, is thrilled to introduce “Cell &amp; Gene: The Podcast.” Cell and gene therapies offer huge potential to treat a wide range of diseases and their possibilities represent a new era in medicine. “Cell &amp; Gene: The Podcast” will explore approved and pipeline therapies, new trends in manufacturing, the long, regulated road to commercialization, and everything in between. In each episode, Cell &amp; Gene Chief Editor, Erin Harris, will talk to an industry or academic leader about their current initiatives and how they are moving the sector forward.  (Music by Royalty Free Music From Bensound)

Enzyvant's Rachelle Jacques on the Biotech’s Lead Asset

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.